Thomas Gajewski News Today

At 11 a.m. on the 11th day of each month church bells will peal at All Souls Church for 11 minutes. The bells ring to signal that we are in the “11th Hour” as our window of opportunity to address catastrophic effects of climate change is rapidly...

You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and related notes... | November 6, 2022

- Internationally renowned researchers Gordon Freeman, Ph.D., Thomas Gajewski, M.D., Ph.D., Jason Luke, M.D., Ignacio Melero, M.D., Ph.D., and Anthony...

- Internationally renowned researchers Gordon Freeman, Ph.D., Thomas Gajewski, M.D., Ph.D., Jason Luke, M.D., Ignacio Melero, M.D., Ph.D., and Anthony Tolcher, M.D., to advise Bright Peak in its mission

Melanoma is, sadly, a cancer that is on the rise. The number of Americans diagnosed annually has increased by over 30 percent in the past decade. However, recent advances in science may give hope to patients with melanoma and their families. In April, CRI CLIP Investigator Nir Hacohen, Ph.D.

You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes thereto... | March 29, 2022

Pyxis Oncology’s IPO raised $168 million as the biotech steers toward the clinic with drug candidates and technology licensed from Pfizer. Theseus Pharma, IsoPlexis, and Cognition Therapeutics also went public; combined the four companies raised nearly half a billion dollars.